NEUROPHET, Inc. (KOSDAQ:380550)
South Korea
· Delayed Price · Currency is KRW
21,000
0.00 (0.00%)
Apr 29, 2026, 9:40 AM KST
NEUROPHET Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Revenue | 2,615 | 2,216 |
| Revenue Growth (YoY) | 18.00% | - |
| Cost of Revenue | 3.91 | 1.27 |
| Gross Profit | 2,611 | 2,215 |
| Selling, General & Admin | 12,337 | 9,739 |
| Research & Development | 5,276 | 5,987 |
| Amortization of Goodwill & Intangibles | 148.53 | 141.42 |
| Other Operating Expenses | 108.99 | 62.28 |
| Operating Expenses | 19,160 | 16,864 |
| Operating Income | -16,549 | -14,649 |
| Interest Expense | -920.64 | -3,614 |
| Interest & Investment Income | 413.26 | 468.72 |
| Currency Exchange Gain (Loss) | -9.89 | -17.5 |
| Other Non Operating Income (Expenses) | -5,323 | 2,713 |
| EBT Excluding Unusual Items | -22,389 | -15,098 |
| Gain (Loss) on Sale of Assets | -0.08 | -3.48 |
| Pretax Income | -22,389 | -15,101 |
| Net Income | -22,389 | -15,101 |
| Net Income to Common | -22,389 | -15,101 |
| Shares Outstanding (Basic) | 10 | 4 |
| Shares Outstanding (Diluted) | 10 | 4 |
| Shares Change (YoY) | 163.48% | - |
| EPS (Basic) | -2302.00 | -4091.00 |
| EPS (Diluted) | -2302.00 | -4091.00 |
| Free Cash Flow | -15,332 | -12,862 |
| Free Cash Flow Per Share | -1576.43 | -3484.24 |
| Gross Margin | 99.85% | 99.94% |
| Operating Margin | -632.84% | -660.98% |
| Profit Margin | -856.15% | -681.41% |
| Free Cash Flow Margin | -586.30% | -580.35% |
| EBITDA | -15,439 | -13,554 |
| D&A For EBITDA | 1,110 | 1,095 |
| EBIT | -16,549 | -14,649 |
| Advertising Expenses | 799.23 | 919.06 |
Source: S&P Capital IQ. Standard template.
Financial Sources.